查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1756482

患者血液管理市場（按產品、組件、最終用戶、國家和地區）－2024 年至 2032 年產業分析、市場規模、市場佔有率及預測

Patient Blood Management Market, By Product, By Component, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 365 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年病患血液管理市場規模價值 154.7898 億美元，2024 年至 2032 年的複合年成長率為 7.98%。

病患血液管理市場-市場動態

貧血和慢性病盛行率上升

貧血以及心血管疾病、癌症和腎臟病等慢性疾病的日益流行，是推動患者血液管理 (PBM) 市場成長的主要動力。這些疾病通常會導致大量失血或紅血球生成減少，因此需要更有效的血液管理策略。隨著全球人口老化和這些疾病發病率的上升，醫療保健提供者正在轉向 PBM 來最佳化血液使用，減少輸血需求，並改善患者預後。 PBM 策略透過客製化療法和介入措施幫助管理貧血，降低輸血相關風險並促進復原。因此，日益加重的慢性疾病負擔正在推動對 PBM 解決方案的需求，這些解決方案專注於最大限度地減少失血，改善紅血球生成，並提供傳統輸血的替代方案。這一趨勢對市場擴張產生了重大影響。

病患血液管理市場-關鍵見解

根據我們的研究分析師，全球患者血液管理市場預計在 2024 年至 2032 年期間的複合年成長率約為 7.98%。

按 2024 年的產品細分，儀器類別佔據了市場主導地位。

根據最終用戶細分，醫院在 2024 年創造了最多的收入。

按地區分類，2024年北美是收入最高的地區。

病患血液管理市場-細分分析：

全球患者血液管理市場分為三類：產品、組件、最終用戶和地區。

患者血液管理 (PBM) 市場分為四個主要產品類別：儀器、配件、試劑和套件以及軟體。其中，儀器預計將佔據市場主導地位。此部分包括用於監測和管理血液相關疾病的血液採集系統、血液處理設備和診斷儀器等設備。儀器的主導地位歸因於它們在實現準確血液分析、減少失血和加強臨床環境中的輸血實踐方面發揮關鍵作用。由於 PBM 強調最大限度地減少失血和最佳化血液使用，因此儀器對於實現這些目標至關重要。此外，醫療技術的進步和節血手術技術的日益普及推動了對創新高性能儀器的需求。精準血液管理在手術和重症監護中的重要性，加上醫療保健投資的增加，使儀器成為 PBM 市場中的領先產品類別。

依最終用戶分類，市場分為血庫、醫院、診斷診所和病理實驗室。其中，醫院將佔據主導地位。醫院是PBM實踐應用最廣泛的主要醫療機構，尤其是在外科手術、創傷護理和重症病人管理方面。由於輸血量、手術量和病人入院量龐大，醫院需要全面的PBM系統來管理失血、最佳化血液使用並降低輸血相關風險。複雜手術數量的增加、慢性病發病率的上升以及對改善患者預後的重視，推動了PBM在醫院的日益普及。此外，醫院擴大採用先進的血液管理技術，有助於PBM實踐的擴展。雖然血庫和診斷診所也在PBM中發揮重要作用，但由於醫院直接參與病患照護和治療，它仍然是主要的最終使用者。

患者血液管理市場-地理洞察

從地理分佈來看，患者血液管理市場分佈於北美、亞太地區、拉丁美洲、歐洲、中東和非洲。這些地區根據業務來源國進一步分類。

北美是患者血液管理 (PBM) 市場的主導地區，這得益於其先進的醫療基礎設施以及醫院和醫療機構日益普及的 PBM 實踐。美國引領這一市場，其醫療保健系統日益重視透過 PBM 解決方案減少輸血相關併發症並最佳化患者治療效果。 FDA 等機構的監管支持，以及人們對 PBM 益處日益成長的認知，進一步推動了其應用。此外，主要市場參與者的存在以及血液管理儀器的持續技術進步，也鞏固了北美市場的領先地位。該地區強勁的醫療支出和需要複雜醫療治療的老齡化人口進一步推動了對 PBM 解決方案的需求。

歐洲是PBM市場的另一個關鍵區域，其顯著成長得益於強大的醫療保健體系、人口老化以及對減少失血和輸血的日益重視。德國、英國和法國等國家引領歐洲市場，這些國家的醫療保健機構擴大採用PBM實踐來提高病患安全性並降低醫療成本。歐盟的醫療保健政策支持PBM策略的實施，尤其是在醫院和外科中心。此外，醫療技術的進步，例如節血手術器械和診斷工具，在推動市場成長方面發揮關鍵作用。歐洲在醫療保健和患者護理方面的進步方法確保了該地區對PBM解決方案的持續需求。

病患血液管理市場-競爭格局：

患者血液管理 (PBM) 市場的競爭態勢由老牌企業和新興創新者共同塑造。 Haemonetics Corporation、Fresenius SE & Co. KGaA、Terumo Corporation 和 Immucor, Inc. 等大公司引領市場，提供一系列先進的 PBM 解決方案，這些解決方案優先考慮安全性、效率和對監管標準的合規性。這些公司非常注重研發，以改善血液管理系統和增強輸血規程。新參與者也帶著創新技術進入市場，例如先進的診斷工具和節血手術器械。這些公司之間的競爭促進了產品的持續改進，並確保了高品質 PBM 解決方案的穩定供應。例如，F. Hoffmann-La Roche Ltd. 和 Grifols, SA 一直在積極擴展其產品組合，而 B. Braun Melsungen AG 和 Bio-Rad Laboratories, Inc. 則繼續透過策略性收購和合作鞏固其地位。

最新動態：

2023年，Grifols從BPL Plasma Inc.收購了美國25家血漿捐贈中心，使其年產能提升約100萬公升。這項策略性舉措鞏固了Grifols在血漿採集領域的全球領導地位，並支持了日益成長的血漿衍生療法需求。此次收購符合Grifols致力於增加患者獲得救命治療的機會的承諾。

2024年10月，Terumo血液與細胞技術公司與美國血液中心合作，在美國推出了Reveos™自動化血液處理系統。此系統可自動將全血分離成血小板、血漿和紅血球等成分，從而簡化流程並提高效率。 Reveos旨在提升血液中心的運作效率，滿足日益成長的血液製品需求。

2022年8月，雅培實驗室推出了一款全新的血液檢測平台，旨在提高患者血液管理中診斷的準確性和速度。此先進平台支援醫療服務提供者及時做出明智的決策，最佳化患者預後，並減少不必要的輸血需求。雅培的創新彰顯了其致力於推動PBM實踐的承諾。

目錄

第 1 章：病患血液管理市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 病患血液管理市場產品片段
    • 病患血液管理市場片段（按組件）
    • 患者血液管理市場片段（按最終用戶）
    • 患者血液管理市場（按國家/地區）
    • 病患血液管理市場（按地區）
  • 競爭洞察

第3章：病患血液管理關鍵市場趨勢

  • 患者血液管理市場促進因素
    • 市場促進因素的影響分析
  • 患者血液管理市場限制
    • 市場限制的影響分析
  • 病患血液管理市場機遇
  • 患者血液管理市場未來趨勢

第4章：病患血液管理產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：病患血液管理市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • 新冠疫情後影響分析
    • 表現最佳的市場區隔
    • 邊際成長細分市場
    • 最鬆散的細分市場
    • 邊際損失市場區隔

第6章：病患血液管理市場格局

  • 2023年病患血液管理市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：患者血液管理市場－依產品

  • 概述
    • 按產品細分的市佔率分析
    • 儀器
      • 血液處理設備
      • 離心機
      • 血球處理器
      • 輸血設備
      • 血液分離機
      • 血漿和血漿成分分離器
      • 細胞回收系統
      • 其他輸血設備
      • 血液培養篩檢設備
      • 自動化血液培養系統
      • 配套實驗室設備
      • 診斷和測試儀器
      • PCR儀器
      • 血液學分析儀
      • NGS平台
      • 血型分析儀
      • 血液儲存設備
      • 醫用冰箱
      • 醫用冷凍櫃
    • 配件
      • 注射器和針頭
      • 小瓶和試管
      • 血袋
      • 其他配件
    • 試劑和試劑盒
      • 血培養基
      • 血型鑑定試劑
      • 玻片染色試劑
      • 檢測試劑盒
      • 其他試劑
    • 軟體
      • 血庫管理軟體
      • 輸血管理軟體
      • 其他軟體

第 8 章：病患血液管理市場 - 按組件

  • 概述
    • 按組件分類的細分市場佔有率分析
    • 全血和紅血球
    • 電漿

第9章：患者血液管理市場－依最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 血庫
    • 醫院
    • 診斷診所和病理實驗室

第 10 章：病患血液管理市場 - 按地區

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美患者血液管理主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按產品）
    • 北美市場規模及預測（按組件）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲患者血液管理主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（按產品）
    • 歐洲市場規模及預測（按組成部分）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區患者血液管理主要製造商
    • 亞太市場規模及預測（按國家/地區）
    • 亞太市場規模及預測（按產品）
    • 亞太市場規模及預測（按組成部分）
    • 亞太市場規模及預測（依最終用戶）
    • 印度
    • 中國
    • 韓國
    • 日本
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲患者血液管理主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按產品）
    • 拉丁美洲市場規模及預測（按組成部分）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲患者血液管理主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按產品）
    • 中東和非洲市場規模及預測（按組成部分）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 11 章：關鍵供應商分析-病患血液管理產業

  • 競爭儀錶板
  • 公司簡介
    • Haemonetics Corporation
    • Fresenius Se & Co. KGaA
    • Terumo Corporation
    • Immucor, Inc.
    • B. Braun Melsungen AG
    • Macopharma
    • Biomerieux SA
    • Kaneka Corporation
    • Bio-Rad Laboratories, Inc.
    • Abbott Laboratories
    • Grifols, SA
    • F. Hoffmann-La Roche Ltd.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5344

REPORT HIGHLIGHT

Patient Blood Management Market size was valued at USD 15,478.98 Million in 2024, expanding at a CAGR of 7.98% from 2024 to 2032.

Patient Blood Management (PBM) is a comprehensive, evidence-based approach aimed at optimizing the care of patients who may require blood transfusions. It focuses on minimizing the need for transfusions by utilizing various strategies such as improving the patient's own blood volume and quality before, during, and after medical procedures. PBM includes three main pillars: optimization of erythropoiesis (promoting the body's natural production of red blood cells), minimization of blood loss (reducing surgical and diagnostic blood loss), and patient-centered transfusion strategies (ensuring transfusions are given only when absolutely necessary). The goal of PBM is to enhance patient outcomes by improving the management of anemia, reducing the risks associated with transfusions, and promoting the use of alternatives. This approach is particularly beneficial in surgical settings, trauma care, and chronic conditions where blood management plays a vital role in recovery and overall health.

Patient Blood Management Market- Market Dynamics

Rising Prevalence of Anemia and Chronic Diseases

The increasing prevalence of anemia and chronic diseases, such as cardiovascular disorders, cancer, and kidney disease, is a major driver for the growth of the Patient Blood Management (PBM) market. These conditions often lead to significant blood loss or decreased red blood cell production, necessitating more effective blood management strategies. As the global population ages and the incidence of these diseases rises, healthcare providers are turning to PBM to optimize blood use, reduce the need for transfusions, and improve patient outcomes. PBM strategies help manage anemia through tailored therapies and interventions, reducing the risks associated with transfusions and enhancing recovery. Consequently, the growing burden of chronic diseases is driving demand for PBM solutions that focus on minimizing blood loss, improving erythropoiesis, and offering alternatives to traditional transfusions. This trend significantly impacts the market's expansion.

PATIENT BLOOD MANAGEMENT Market- Key Insights

According to our research analyst, the global Patient Blood Management Market is expected to develop at a CAGR of approximately 7.98% between 2024-2032.

Segmented by Product in 2024, the Instruments category dominated the market.

Based on End User segmentation, the Hospitals generated the most income in 2024.

Based on region, in 2024, North America was the region with the highest revenue.

Patient Blood Management Market- Segmentation Analysis:

The global Patient Blood Management market is divided into three categories: product, component, end user and region.

The Patient Blood Management (PBM) market is segmented into four key product categories: Instruments, Accessories, Reagents and Kits, and Software. Among these, Instruments are expected to dominate the market. This segment includes devices such as blood collection systems, blood processing equipment, and diagnostic instruments used to monitor and manage blood-related conditions. The dominance of instruments is attributed to their critical role in enabling accurate blood analysis, reducing blood loss, and enhancing transfusion practices in clinical settings. As PBM emphasizes minimizing blood loss and optimizing blood use, instruments are central to these objectives. Additionally, advancements in medical technologies and the growing adoption of blood-saving surgical techniques drive the demand for innovative, high-performance instruments. The importance of precise blood management in surgeries and critical care, coupled with increasing healthcare investments, positions instruments as the leading product category within the PBM market.

By End User the market is segmented into Blood Banks, Hospitals and Diagnostic Clinics and & Pathology Labs. Among these, the Hospitals segment is set to dominate. Hospitals are the primary healthcare settings where PBM practices are most extensively applied, particularly in surgical procedures, trauma care, and critical patient management. With the high volume of blood transfusions, surgeries, and patient admissions, hospitals require comprehensive PBM systems to manage blood loss, optimize blood use, and reduce transfusion-related risks. The growing adoption of PBM in hospitals is driven by the increasing number of complex surgeries, the rising incidence of chronic diseases, and the emphasis on improving patient outcomes. Additionally, hospitals are increasingly implementing advanced technologies for blood management, contributing to the expansion of PBM practices. While blood banks and diagnostic clinics also play essential roles in PBM, hospitals remain the dominant end user due to their direct involvement in patient care and treatment.

Patient Blood Management Market- Geographical Insights

Geographically, the Patient Blood Management Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Patient Blood Management (PBM) market, driven by the advanced healthcare infrastructure and the growing adoption of PBM practices in hospitals and healthcare facilities. The U.S. leads the market, where healthcare systems are increasingly focusing on reducing transfusion-related complications and optimizing patient outcomes through PBM solutions. Regulatory support from agencies like the FDA, along with rising awareness about the benefits of PBM, further fuels its adoption. Additionally, the presence of key market players and continuous technological advancements in blood management instruments contribute to North America's market leadership. The region's robust healthcare spending and an aging population requiring complex medical treatments further drive the demand for PBM solutions.

Europe is another key region in the PBM market, with significant growth attributed to a strong healthcare system, an aging population, and an increasing emphasis on minimizing blood loss and transfusions. Countries such as Germany, the U.K., and France lead the European market, with healthcare providers increasingly adopting PBM practices to enhance patient safety and reduce healthcare costs. The European Union's healthcare policies support the adoption of PBM strategies, particularly in hospitals and surgical centers. In addition, advancements in medical technology, such as blood-saving surgical instruments and diagnostic tools, play a pivotal role in driving market growth. Europe's progressive approach to healthcare and patient care ensures continued demand for PBM solutions in the region.

Patient Blood Management Market- Competitive Landscape:

The competitive dynamics of the Patient Blood Management (PBM) market are shaped by both established players and emerging innovators. Major companies like Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, and Immucor, Inc. lead the market, offering a range of advanced PBM solutions that prioritize safety, efficiency, and compliance with regulatory standards. These companies focus heavily on research and development to improve blood management systems and enhance transfusion protocols. New players are also entering the market with innovative technologies, such as advanced diagnostic tools and blood-saving surgical instruments. The competition among these companies encourages continuous product advancements and ensures a steady supply of high-quality PBM solutions. For instance, F. Hoffmann-La Roche Ltd. and Grifols, S.A. have been actively expanding their product portfolios, while B. Braun Melsungen AG and Bio-Rad Laboratories, Inc. continue to strengthen their positions through strategic acquisitions and collaborations.

Recent Developments:

In 2023, Grifols acquired 25 plasma donation centers in the U.S. from BPL Plasma Inc., enhancing its capacity by approximately 1 million liters annually. This strategic move strengthens Grifols' global leadership in plasma collection, supporting the growing demand for plasma-derived therapies. The acquisition aligns with Grifols' commitment to increasing patient access to life-saving treatments.

In October 2024, Terumo Blood and Cell Technologies introduced the Reveos(TM) Automated Blood Processing System in the U.S., in collaboration with Blood Centers of America. This innovative system automates the separation of whole blood into its components platelets, plasma, and red blood cells streamlining the process and improving efficiency. Reveos aims to enhance blood center operations and meet the increasing demand for blood products.

In August 2022, Abbott Laboratories launched a new blood testing platform designed to improve the accuracy and speed of diagnostics in patient blood management. This advanced platform supports healthcare providers in making timely and informed decisions, optimizing patient outcomes, and reducing the need for unnecessary transfusions. Abbott's innovation underscores its commitment to advancing PBM practices.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PATIENT BLOOD MANAGEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Haemonetics Corporation
  • Fresenius Se & Co. KGaA
  • Terumo Corporation
  • Immucor, Inc.
  • B. Braun Melsungen AG
  • Macopharma
  • Biomerieux SA
  • Kaneka Corporation
  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories
  • Grifols, S.A.
  • F. Hoffmann-La Roche Ltd.
  • Others

GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Instruments
  • Blood Processing Devices
  • Centrifuges
  • Blood Cell Processors
  • Blood Transfusion Devices
  • Apheresis Machines
  • Plasma & Plasma Component Separators
  • Cell Salvage Systems
  • Other Transfusion Devices
  • Blood Culture Screening Devices
  • Automated Blood Culture Systems
  • Supporting Laboratory Equipment
  • Diagnostic & Testing Instruments
  • PCR Instruments
  • Hematology Analyzers
  • NGS Platforms
  • Blood Grouping Analyzers
  • Blood Storage Devices
  • Medical Refrigerators
  • Medical Freezers
  • Accessories
  • Syringes & Needles
  • Vials & Tubes
  • Blood Bags
  • Other Accessories
  • Reagents and Kits
  • Blood Culture Media
  • Blood Typing Reagents
  • Slide Staining Reagents
  • Assay Kits
  • Other Reagents
  • Software
  • Blood Bank Management Software
  • Transfusion Management Software
  • Other Software

GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Whole Blood & Red Blood Cells
  • Plasma

GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Blood Banks
  • Hospitals
  • Diagnostic Clinics and & Pathology Labs

GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Patient Blood Management Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Patient Blood Management Market Snippet by Product
    • 2.1.2. Patient Blood Management Market Snippet by Component
    • 2.1.3. Patient Blood Management Market Snippet by End User
    • 2.1.4. Patient Blood Management Market Snippet by Country
    • 2.1.5. Patient Blood Management Market Snippet by Region
  • 2.2. Competitive Insights

3. Patient Blood Management Key Market Trends

  • 3.1. Patient Blood Management Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Patient Blood Management Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Patient Blood Management Market Opportunities
  • 3.4. Patient Blood Management Market Future Trends

4. Patient Blood Management Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Patient Blood Management Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Patient Blood Management Market Landscape

  • 6.1. Patient Blood Management Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Patient Blood Management Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Instruments
      • 7.1.2.1. Blood Processing Devices
      • 7.1.2.1.1. Centrifuges
      • 7.1.2.1.2. Blood Cell Processors
      • 7.1.2.2. Blood Transfusion Devices
      • 7.1.2.2.1. Apheresis Machines
      • 7.1.2.2.2. Plasma & Plasma Component Separators
      • 7.1.2.2.3. Cell Salvage Systems
      • 7.1.2.2.4. Other Transfusion Devices
      • 7.1.2.3. Blood Culture Screening Devices
      • 7.1.2.3.1. Automated Blood Culture Systems
      • 7.1.2.3.2. Supporting Laboratory Equipment
      • 7.1.2.4. Diagnostic & Testing Instruments
      • 7.1.2.4.1. PCR Instruments
      • 7.1.2.4.2. Hematology Analyzers
      • 7.1.2.4.3. NGS Platforms
      • 7.1.2.4.4. Blood Grouping Analyzers
      • 7.1.2.5. Blood Storage Devices
      • 7.1.2.5.1. Medical Refrigerators
      • 7.1.2.5.2. Medical Freezers
    • 7.1.3. Accessories
      • 7.1.3.1. Syringes & Needles
      • 7.1.3.2. Vials & Tubes
      • 7.1.3.3. Blood Bags
      • 7.1.3.4. Other Accessories
    • 7.1.4. Reagents and Kits
      • 7.1.4.1. Blood Culture Media
      • 7.1.4.2. Blood Typing Reagents
      • 7.1.4.3. Slide Staining Reagents
      • 7.1.4.4. Assay Kits
      • 7.1.4.5. Other Reagents
    • 7.1.5. Software
      • 7.1.5.1. Blood Bank Management Software
      • 7.1.5.2. Transfusion Management Software
      • 7.1.5.3. Other Software

8. Patient Blood Management Market - By Component

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
    • 8.1.2. Whole Blood & Red Blood Cells
    • 8.1.3. Plasma

9. Patient Blood Management Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Blood Banks
    • 9.1.3. Hospitals
    • 9.1.4. Diagnostic Clinics and & Pathology Labs

10. Patient Blood Management Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Patient Blood Management Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Patient Blood Management Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Patient Blood Management Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Patient Blood Management Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Patient Blood Management Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Patient Blood Management Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Haemonetics Corporation
    • 11.2.2. Fresenius Se & Co. KGaA
    • 11.2.3. Terumo Corporation
    • 11.2.4. Immucor, Inc.
    • 11.2.5. B. Braun Melsungen AG
    • 11.2.6. Macopharma
    • 11.2.7. Biomerieux SA
    • 11.2.8. Kaneka Corporation
    • 11.2.9. Bio-Rad Laboratories, Inc.
    • 11.2.10. Abbott Laboratories
    • 11.2.11. Grifols, S.A.
    • 11.2.12. F. Hoffmann-La Roche Ltd.
    • 11.2.13. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us